A Multicenter, Open-label, Single-arm Study of a Pertuzumab in Combination With Trastuzumab and a Taxane in First Line Treatment of Patients With HER2- Positive Advanced (Metastatic or Locally Recurrent) Breast Cancer

drug protocol number
MO28047
drug sponsor
Roche
drug study
Pertuzumab + Trastuzumab +Taxane
drug trial site
KFSH & RC-R
drug status
Completed
drug phase